Ventas (VEN) AI Stock Analysis

Ventas

(Frankfurt:VEN)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Senior Housing Operating GrowthSustained double-digit SHOP NOI growth indicates durable operating momentum rather than a single-quarter improvement. It reflects stronger occupancy, pricing, and property-level profitability, supporting recurring cash-flow growth and giving Ventas a foundation for further investment and earnings expansion.

Negative Factors

Elevated LeverageHistorically elevated leverage can constrain financial flexibility for a rate-sensitive REIT, particularly when debt must be refinanced. Higher obligations may limit acquisition capacity, increase exposure to financing costs, and reduce the resources available for dividends or property investment during weaker operating periods.

Ventas (VEN) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 44.48B
Dividend Yield: 2.49%
Average Volume (3M): 84
Price to Earnings (P/E): 157.1
Beta (1Y): 0.07
Revenue Growth: 16.25%
EPS Growth: -4.62%
Country: Germany
Employees: 542
Sector: Real Estate
Sector Strength: 65
Industry: REIT - Healthcare Facilities

Ventas Business Overview & Revenue Model

Company Description

Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity ec...

Ventas Earnings Call Summary

Earnings Call Date:Oct 26, 2026(Q3-2026)|% Change Since:-6.18%|Next Earnings Date:Feb 16, 2027

Earnings Call SentimentPositive

The call was strongly positive, characterized by record company same-store growth, 17 consecutive quarters of double-digit SHOP NOI growth, improving occupancy and margins, increased FFO guidance, substantial investment activity, stronger leverage, and a robust acquisition pipeline. The company cited limited challenges from research portfolio performance, quarterly utility costs, higher interest rates, FX, acquisition competition, and lower-priority international markets, but these did not outweigh the reported operating momentum and outlook.

Positive Updates

Strong Enterprise and Same-Store Performance

Ventas reported 11% total company same-store cash NOI growth, a record-high company growth rate, led by 16% SHOP same-store cash NOI growth. U.S. SHOP same-store cash NOI grew 17%.

Negative Updates

Research Portfolio Decline

Ventas's research portfolio, which represents a small portion of NOI, experienced a modest decline in the third quarter, although management said the decline was expected.

Company Guidance

Ventas raised full year net income guidance to $0.64 to $0.67 per share or $0.66 per share at the midpoint, and increased full year normalized FFO per share guidance to now range from $3.87 to $3.90 per share, which represents year over year growth of 9% to 10%; the guidance includes closed investments of $5.2 billion, assumes refinancing maturing debt in the coming months, and expects the majority of disposition and loan repayment guidance of $700 million at a 7% yield to close in the fourth quarter. Same store cash NOI guidance was reaffirmed for each segment and for the total company. Senior housing investments are expected to produce double digit to mid teens unlevered IRRs and year-1 average yields in the mid-6s, while next year’s in house rent increases are expected to be around the same or better.

Ventas Risk Analysis

Ventas disclosed 52 risk factors in its most recent earnings report. Ventas reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Ventas Peers Comparison

Overall Rating

UnderperformOutperform

Sector (65)

Financial Indicators

DE:VEN against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CTRE	80Outperform	$8.60B	22.60	8.54%	4.14%	53.07%	32.48%
OHI	80Outperform	$14.24B	16.26	16.51%	5.73%	15.18%	72.69%
DOC	71Outperform	$13.45B	54.37	3.30%	6.41%	5.52%	48.98%
WELL	70Outperform	$172.10B	113.34	3.23%	1.31%	39.11%	-140.16%
Sector *	65Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
HR	60Neutral	$6.26B	-129.94	-1.04%	5.19%	-6.28%	77.63%

* Real Estate Sector Average

Performance Comparison

DE:VEN and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:VEN	Ventas Inc	73.22	11.19	18.04%
DOC	Healthpeak Properties, Inc.	19.03	2.61	15.90%
WELL	Welltower, Inc.	234.60	52.92	29.13%
OHI	Omega Healthcare Investors	46.98	5.80	14.09%
HR	Healthcare Realty Trust Incorporated	18.49	1.75	10.46%
CTRE	CareTrust REIT	36.39	2.39	7.03%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Ventas AI Stock Analysis